Narrative Update: Maire Price Target Adjustment
Analysts have raised their price target for Maire from €14.19 to €14.33. This change reflects expectations for improved growth and profitability metrics.
What's in the News
- Maire S.p.A. is actively pursuing several bolt-on acquisitions in Europe and is targeting signing agreements before the end of the year (Key Developments).
- The company plans to prioritize expanding its technology portfolio and will continue investing in growth through selective acquisitions (Key Developments).
- Profitability is expected to reach the upper end of Maire's guidance range, with operating cash generation supporting a strong net cash position for year-end 2024 (Key Developments).
Valuation Changes
- Fair Value increased slightly from €14.19 to €14.33.
- Discount Rate rose marginally from 12.55% to 12.58%.
- Revenue Growth is projected to rise from 5.22% to 5.43%.
- Net Profit Margin improved modestly from 4.24% to 4.33%.
- Future P/E increased slightly from 18.74x to 18.88x.
Have other thoughts on Maire?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.